#Parker Institute for Cancer Immunotherapy

US unanimously approves CRISPR in humans

3 years ago — Quick Read

The National Institute of Health’s Recombinant DNA Advisory Committee, a US ethics and biosafety panel, has permitted research to allow the use of CRISPR/cas9 in creating genetically altered immune cells to...